Healthcare Professional Resources

Resources to Support Neuroendocrine Cancer Care

Access trusted, evidence-based materials to support the diagnosis, treatment, and management of neuroendocrine cancer in clinical practice.

Alternatively, you can order printed resources here.

Filter by:
Or browse by popular tag:
Advocacy & Awareness Videos

NeuroEndocrine Cancer Australia Thankyou Video

HCP Videos

Neuroendocrine Cancer Symptoms: Full Interview with Dr David Chan

HCP Videos

Neuroendocrine Cancer Symptoms: Full Interview with Dr John Leyden

HCP Videos

Neuroendocrine Cancer Symptoms: Full Interview with Prof Nick Pavlakis

HCP Videos

Neuroendocrine Cancer Symptoms: Specialist interview: Dr Bill Macdonald and Dr David Ransom

HCP Videos

Neuroendocrine Cancer Symptoms: With Dr Gabrielle Cehic AM

HCP Videos

Neuroendocrine Cancer Symptoms: With Meredith Cummins

Courses

Neuroendocrine Tumour Education Course

Booklets & Guides

Neuroendocrine tumours: A guide for healthcare professionals

Clinical Trials

ONJCRI Immunotherapy Trial: Nivolumab & Ipilimumab for Rare and Advanced Cancers

This protocol provides an important opportunity to establish whether the combination of nivolumab & ipilimumab has efficacy in these cancers.
Educational Videos

Optimal Care Pathway for Neuroendocrine Tumours (NETs)

Clinical Trials

PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET)

PARLuNET is a phase 1 dose-escalation study designed to evaluate the safety and tolerability of talazoparib (PARP Inhibitor) in...
Other Resources

Patient Card – Carcinoid Crisis Medical Alert

Clinical Trials

Phase 3 Trial of CAM2029 vs Standard Treatments in GEP-NET Patients

The purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET.
Fact Sheets

Quick Facts

Booklets & Guides

Quick Reference Guide
for Healthcare Professionals

Tax Appeal

Screenshot 2026-05-20 at 2.12.07 PM

Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.

Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.